{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T20:59:28Z","timestamp":1771016368597,"version":"3.50.1"},"reference-count":79,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1097\/01.inf.0000259996.95965.ef","type":"journal-article","created":{"date-parts":[[2007,4,23]],"date-time":"2007-04-23T08:03:18Z","timestamp":1177315398000},"page":"371-376","source":"Crossref","is-referenced-by-count":30,"title":["Use of Meningococcal Vaccines in the United States"],"prefix":"10.1097","volume":"26","author":[{"given":"Oleg","family":"Bilukha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Messonnier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"RR-7","key":"R1-2-20210202","first-page":"1","article-title":"Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"54","year":"2005","journal-title":"MMWR"},{"key":"R2-2-20210202","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0022-3476(81)80250-8","article-title":"Complications and sequelae of meningococcal infections in children.","volume":"99","author":"Edwards","year":"1981","journal-title":"J Pediatr"},{"key":"R3-2-20210202","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/00006454-199611000-00009","article-title":"Pathophysiology, treatment and outcome of meningococcemia: a review and recent experience.","volume":"15","author":"Kirsch","year":"1996","journal-title":"Pediatr Infect Dis"},{"key":"R4-2-20210202","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1001\/jama.286.6.688","article-title":"Risk factors for meningococcal disease in college students.","volume":"286","author":"Bruce","year":"2001","journal-title":"JAMA"},{"key":"R5-2-20210202","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1086\/520166","article-title":"Meningococcal disease in college students.","volume":"29","author":"Froeschle","year":"1999","journal-title":"Clin Infect Dis"},{"key":"R6-2-20210202","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/jama.281.20.1906","article-title":"Risk of meningococcal infection in college students.","volume":"281","author":"Harrison","year":"1999","journal-title":"JAMA"},{"key":"R7-2-20210202","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1017\/S0950268899002368","article-title":"Invasive meningococcal disease among university undergraduates: association with universities providing relatively large amounts of catered hall accommodations.","volume":"122","author":"Neal","year":"1999","journal-title":"Epidemiol Infect"},{"key":"R8-2-20210202","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1045-1870(97)80009-X","article-title":"Neisseria meningitidis serogroup B: emergence of the ET-5 complex.","volume":"8","author":"Fischer","year":"1997","journal-title":"Semin Pediatr Infect Dis"},{"key":"R9-2-20210202","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1086\/315158","article-title":"The changing epidemiology of meningococcal disease in the United States, 1992\u20131996.","volume":"180","author":"Rosenstein","year":"1999","journal-title":"J Infect Dis"},{"key":"R10-2-20210202","first-page":"317","article-title":"Immunogenicity and side-effects of a new tetravalent meningococcal polysaccharide vaccine.","volume":"61","author":"Ambrosch","year":"1983","journal-title":"Bull World Health Organ"},{"key":"R11-2-20210202","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM197002192820803","article-title":"Prevention of meningococcal disease by group C polysaccharide vaccine.","volume":"282","author":"Artenstein","year":"1970","journal-title":"N Engl J Med"},{"key":"R12-2-20210202","first-page":"279","article-title":"Meningococcal infections. 2. Field trial of group C meningococcal polysaccharide vaccine in 1969\u201370.","volume":"45","author":"Gold","year":"1971","journal-title":"Bull World Health Organ"},{"key":"R13-2-20210202","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/infdis\/154.6.1033","article-title":"Reactogenicity and immunogenicity of a quadrivalent combined meningococcal polysaccharide vaccine in children.","volume":"154","author":"Lepow","year":"1986","journal-title":"J Infect Dis"},{"key":"R14-2-20210202","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0140-6736(85)90224-7","article-title":"Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine.","volume":"2","author":"Reingold","year":"1985","journal-title":"Lancet"},{"key":"R15-2-20210202","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/jama.279.6.435","article-title":"Efficacy of meningococcal vaccine and barriers to vaccination.","volume":"279","author":"Rosenstein","year":"1998","journal-title":"JAMA"},{"key":"R16-2-20210202","first-page":"14","article-title":"Local adverse effects of meningococcal vaccine.","volume":"150","author":"Scheifele","year":"1994","journal-title":"Can Med Assoc J"},{"key":"R17-2-20210202","first-page":"5","article-title":"Abstracts of the 14th International Pathogenic Neisseria Conference, Milwaukee, Wisconsin, 2004;","author":"Soriano-Gabarro","year":"2004"},{"key":"R18-2-20210202","doi-asserted-by":"crossref","first-page":"77","DOI":"10.53393\/rial.1978.38.37124","article-title":"Assessment of the protection conferred by anti-group C meningococcal polysaccharide vaccine to 6 to 36 month-old children [Portuguese].","volume":"38","author":"Taunay","year":"1978","journal-title":"Rev Inst Adolfo Lutz"},{"key":"R19-2-20210202","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0092-1157(82)80010-3","article-title":"Tetravalent meningococcal polysaccharide vaccine groups A, C, Y, W 135: clinical and serologic evaluation.","volume":"10","author":"Armand","year":"1982","journal-title":"J Biol Stand"},{"key":"R20-2-20210202","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1093\/infdis\/165-Supplement_1-S49","article-title":"Thymus-independent and thymus-dependent responses to polysaccharide antigens.","volume":"165","author":"Stein","year":"1992","journal-title":"J Infect Dis"},{"key":"R21-2-20210202","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1542\/peds.60.5.673","article-title":"Persistence of antibody following immunization of children with groups A and C meningococcal polysaccharide vaccines.","volume":"60","author":"Lepow","year":"1977","journal-title":"Pediatrics"},{"key":"R22-2-20210202","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1172\/JCI108235","article-title":"Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants.","volume":"56","author":"Gold","year":"1975","journal-title":"J Clin Invest"},{"key":"R23-2-20210202","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1056\/NEJM197709292971302","article-title":"Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age.","volume":"297","author":"Peltola","year":"1977","journal-title":"N Engl J Med"},{"key":"R24-2-20210202","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1093\/infdis\/136.Supplement.S31","article-title":"Immune response of human infants to polysaccharide vaccines of group A and C Neisseria meningitidis.","volume":"136","author":"Gold","year":"1977","journal-title":"J Infect Dis"},{"key":"R25-2-20210202","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0022-3476(96)70389-X","article-title":"Total and functional antibody response to a quadrivalent meningococcal polysaccharide vaccine among children.","volume":"128","author":"King","year":"1996","journal-title":"J Pediatr"},{"key":"R26-2-20210202","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1128\/IAI.66.6.2453-2459.1998","article-title":"Age-dependent Neisseria meningitidis serogroup C class-specific antibody concentrations and bactericidal titers in sera from young children from Montana immunized with a licensed polysaccharide vaccine.","volume":"66","author":"Maslanka","year":"1998","journal-title":"Infect Immun"},{"key":"R27-2-20210202","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1203\/00006450-197404000-00537","article-title":"Disease prevention by meningococcal serogroup C polysaccharide vaccine in preschool children: results after eleven months in Sao Paulo, Brazil.","volume":"8","author":"Taunay","year":"1974","journal-title":"Pediatr Res"},{"key":"R28-2-20210202","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0264-410X(00)00317-0","article-title":"Reduced antibody response to revaccination with meningococcal serogroup A polysaccharide vaccine in adults.","volume":"19","author":"Borrow","year":"2000","journal-title":"Vaccine"},{"key":"R29-2-20210202","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1086\/515346","article-title":"Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination.","volume":"178","author":"Granoff","year":"1998","journal-title":"J Infect Dis"},{"key":"R30-2-20210202","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/jama.280.19.1685","article-title":"Induction of immunologic memory by conjugates vs. plain meningococcal C polysaccharide vaccine in toddlers.","volume":"280","author":"MacDonald","year":"1998","journal-title":"JAMA"},{"key":"R31-2-20210202","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1016\/S0264-410X(99)00139-5","article-title":"Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunization during early childhood.","volume":"17","author":"MacLennan","year":"1999","journal-title":"Vaccine"},{"key":"R32-2-20210202","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0163-4453(88)96117-8","article-title":"Meningococcal carriage, meningococcal disease and vaccination.","volume":"16","author":"Hassan-King","year":"1988","journal-title":"J Infect"},{"key":"R33-2-20210202","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1001\/jama.1988.03410180094036","article-title":"Group A meningococcal carriage in travelers returning from Saudi Arabia.","volume":"260","author":"Moore","year":"1988","journal-title":"JAMA"},{"key":"R34-2-20210202","first-page":"435","article-title":"Regulatory Perspectives in Vaccine Licensure.","author":"Frasch","year":"1994"},{"key":"R35-2-20210202","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1001\/jama.1993.03500020055031","article-title":"Decline of childhood Haemophilus influenzae type b disease in the Hib vaccine era.","volume":"269","author":"Adams","year":"1993","journal-title":"JAMA"},{"key":"R36-2-20210202","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"R37-2-20210202","first-page":"93","article-title":"Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines.","volume":"171","author":"Mohle-Boetani","year":"1993","journal-title":"Pediatr Infect Dis J"},{"key":"R38-2-20210202","article-title":"Effect of a 7-valent conjugate vaccine on nasopharyngeal carriage among Navajo and White Mountain Apache infants. Paper presented at: 19th Annual Meeting of the European Society of Pediatric Infectious Diseases,","author":"O'Brien","year":"2001"},{"key":"R39-2-20210202","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/infdis\/164.5.982","article-title":"Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine.","volume":"164","author":"Takala","year":"1991","journal-title":"J Infect Dis"},{"key":"R40-2-20210202","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1046\/j.1440-1754.2001.00738.x","article-title":"Introduction of a conjugate meningococcal type C vaccine programme in the UK.","volume":"37","author":"Salisbury","year":"2001","journal-title":"J Paediatr Child Health"},{"key":"R41-2-20210202","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(03)12563-9","article-title":"Effectiveness of meningococcal C conjugate vaccine in teenagers in England.","volume":"361","author":"Bose","year":"2003","journal-title":"Lancet"},{"key":"R42-2-20210202","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0140-6736(00)03594-7","article-title":"Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England.","volume":"357","author":"Ramsay","year":"2001","journal-title":"Lancet"},{"key":"R43-2-20210202","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(04)16725-1","article-title":"Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction.","volume":"364","author":"Trotter","year":"2004","journal-title":"Lancet"},{"key":"R44-2-20210202","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(02)08679-8","article-title":"Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination.","volume":"359","author":"Maiden","year":"2002","journal-title":"Lancet"},{"key":"R45-2-20210202","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/bmj.326.7385.365","article-title":"Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis.","volume":"326","author":"Ramsay","year":"2003","journal-title":"BMJ"},{"key":"R46-2-20210202","first-page":"1023","article-title":"Guillain-Barr\u00e9 syndrome among recipients of Menactra\u00ae meningococcal conjugate vaccine\u2014United States, June\u2013July 2005.","volume":"54","year":"2005","journal-title":"MMWR"},{"key":"R47-2-20210202","first-page":"364","article-title":"Update: Guillain-Barr\u00e9 syndrome among recipients of Menactra\u00ae meningococcal conjugate vaccine\u2014United States, October 2005\u2013February 2006.","volume":"55","year":"2006","journal-title":"MMWR"},{"key":"R48-2-20210202","first-page":"1120","article-title":"Update: Guillain-Barr\u00e9 syndrome among recipients of Menactra\u00ae meningococcal conjugate vaccine\u2014United States, June 2005\u2013September 2006.","volume":"55","year":"2006","journal-title":"MMWR"},{"key":"R49-2-20210202","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1542\/peds.2005-1314","article-title":"Prevention and control of meningococcal disease: recommendations for use of meningococcal vaccines in pediatric patients.","volume":"116","year":"2005","journal-title":"Pediatrics"},{"key":"R50-2-20210202","first-page":"567","article-title":"Notice to readers: limited supply of meningococcal conjugate vaccine, recommendation to defer vaccination of persons aged 11\u201312 years.","volume":"55","year":"2006","journal-title":"MMWR"},{"key":"R51-2-20210202","first-page":"1177","article-title":"Notice to readers: improved supply of meningococcal conjugate vaccine, recommendation to resume vaccination of persons aged 11\u201312 years.","volume":"55","year":"2006","journal-title":"MMWR"},{"key":"R52-2-20210202","first-page":"141","article-title":"Laboratory-acquired meningococcal disease\u2014United States, 2000.","volume":"51","year":"2002","journal-title":"MMWR"},{"key":"R53-2-20210202","first-page":"5","article-title":"Evolution of Meningococccal Disease. 1st ed.","volume":"1","author":"Brundage","year":"1987"},{"key":"R54-2-20210202","article-title":"Traveler's Health: Yellow Book. Meningococcal Disease.","year":"2005"},{"key":"R55-2-20210202","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1128\/CMR.4.3.359","article-title":"Infectious diseases associated with complement deficiencies.","volume":"4","author":"Figueroa","year":"1991","journal-title":"Clin Microbiol Rev"},{"key":"R56-2-20210202","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1046\/j.1365-2249.1998.00738.x","article-title":"Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine.","volume":"114","author":"Fijen","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"R57-2-20210202","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0039-6109(16)42339-X","article-title":"Postsplenectomy infection.","volume":"61","author":"Francke","year":"1981","journal-title":"Surg Clin North Am"},{"key":"R58-2-20210202","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1016\/S0264-410X(03)00440-7","article-title":"Long term effects of vaccination of patients deficient in a late complement component with a tetravalent meningococcal polysaccharide vaccine.","volume":"21","author":"Platonov","year":"2003","journal-title":"Vaccine"},{"key":"R59-2-20210202","doi-asserted-by":"crossref","first-page":"182","DOI":"10.7326\/0003-4819-132-3-200002010-00003","article-title":"Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California.","volume":"132","author":"Nuorti","year":"2000","journal-title":"Ann Intern Med"},{"key":"R60-2-20210202","doi-asserted-by":"crossref","first-page":"937","DOI":"10.7326\/0003-4819-123-12-199512150-00007","article-title":"Sporadic meningococcal disease in adults: results of a 5-year population-based study.","volume":"123","author":"Stephens","year":"1995","journal-title":"Ann Intern Med"},{"issue":"RR-5","key":"R61-2-20210202","first-page":"1","article-title":"Control and prevention of meningococcal disease and control and prevention of serogroup C meningococcal disease: evaluation and management of suspected outbreaks; recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"46","year":"1997","journal-title":"MMWR"},{"key":"R62-2-20210202","first-page":"1016","article-title":"Inadvertent misadministration of meningococcal conjugate vaccine\u2014United States, June\u2013August 2005.","volume":"55","year":"2006","journal-title":"MMWR"},{"key":"R63-2-20210202","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1097\/00006454-200210000-00019","article-title":"Dose escalation, safety and immunogenicity study of a tetravalent meningococcal polysaccharide diphtheria conjugate vaccine in toddlers.","volume":"21","author":"Rennels","year":"2002","journal-title":"Pediatr Infect Dis"},{"key":"R64-2-20210202","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/01.inf.0000126297.28952.f8","article-title":"Dosage escalation, safety and immunogenicity study of four dosages of a tetravalent meningococcal polysaccharide diphtheria toxoid conjugate vaccine in infants.","volume":"23","author":"Rennels","year":"2004","journal-title":"Pediatr Infect Dis"},{"key":"R65-2-20210202","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/01.inf.0000148928.10057.86","article-title":"Comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y, W-135) meningococcal polysaccharide-diphtheria conjugate vaccine versus quadrivalent polysaccharide vaccine in two- to ten-year-old children.","volume":"24","author":"Pichichero","year":"2005","journal-title":"Pediatr Infect Dis"},{"key":"R66-2-20210202","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/infdis\/126.5.514","article-title":"Immunological response of man to group B meningococcal polysaccharide vaccines.","volume":"126","author":"Wyle","year":"1972","journal-title":"J Infect Dis"},{"key":"R67-2-20210202","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.4049\/jimmunol.129.5.2172","article-title":"Measurement of antibodies to meningococcal serogroup B polysaccharide: low avidity binding and equilibrium binding constants.","volume":"129","author":"Mandrell","year":"1982","journal-title":"J Immunol"},{"key":"R68-2-20210202","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1128\/IAI.40.1.257-264.1983","article-title":"Importance of the complement source in bactericidal activity of human antibody and murine model antibody to meningococcal group B polysaccharide.","volume":"40","author":"Zollinger","year":"1983","journal-title":"Infect Immun"},{"key":"R69-2-20210202","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.4049\/jimmunol.138.12.4402","article-title":"An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polyscialic acid units of glycoproteins in neural and extraneural tissues.","volume":"138","author":"Finne","year":"1987","journal-title":"J Immunol"},{"key":"R70-2-20210202","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","article-title":"Antigenic similarities between brain components and bacteria causing meningitis.","volume":"2","author":"Finne","year":"1983","journal-title":"Lancet"},{"key":"R71-2-20210202","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1517\/13543784.7.2.245","article-title":"Meningococcal vaccine development: a novel approach.","volume":"7","author":"Fusco","year":"1998","journal-title":"Exp Opin Invest Drugs"},{"key":"R72-2-20210202","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/infdis\/175.2.364","article-title":"Preclinical evaluation of a novel group B meningococcal conjugate vaccine that elicits bactericidal activity in both mice and nonhuman primates.","volume":"175","author":"Fusco","year":"1997","journal-title":"J Infect Dis"},{"key":"R73-2-20210202","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1046\/j.1440-1754.2001.00722.x","article-title":"A 10-year serogroup B meningococcal disease epidemic in New Zealand: descriptive epidemiology, 1991\u20132000.","volume":"37","author":"Baker","year":"2001","journal-title":"J Paediatr Child Health"},{"key":"R74-2-20210202","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/jama.281.16.1541","article-title":"Serogroup B meningococcal disease: new outbreaks, new strategies [editorial].","volume":"281","author":"Wenger","year":"1999","journal-title":"JAMA"},{"key":"R75-2-20210202","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1016\/S0264-410X(99)00044-4","article-title":"Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (Por A) outer membrane proteins.","volume":"17","author":"Cartwright","year":"1999","journal-title":"Vaccine"},{"key":"R76-2-20210202","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1128\/JCM.38.9.3323-3328.2000","article-title":"Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States. The Active Bacterial Core Surveillance Team.","volume":"38","author":"Tondella","year":"2000","journal-title":"J Clin Microbiol"},{"key":"R77-2-20210202","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0264-410X(01)00410-8","article-title":"Vaccine prevention of meningococcal disease, coming soon.","volume":"20","author":"Morley","year":"2002","journal-title":"Vaccine"},{"key":"R78-2-20210202","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/35006655","article-title":"Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491.","volume":"404","author":"Parkhill","year":"2000","journal-title":"Nature"},{"key":"R79-2-20210202","first-page":"33","article-title":"Recent developments in vaccines to prevent meningococcal serogroup B infections.","volume":"5","author":"Vermont","year":"2003","journal-title":"Curr Opin Mol Ther"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006454-200705000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T21:43:55Z","timestamp":1736977435000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-200705000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":79,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/01.inf.0000259996.95965.ef","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}